Possible link between NO concentrations and COX-2 expression in systems treated with soy-isoflavones

Annals of the New York Academy of Sciences

Volumn 1095, Issue , 2007, Pages 564-573

  Shin, Jang In ^a   Lee, Yun Kyung ^a   Young, Min Kim ^a   Hwang, Jin Taek ^b   Ock, Jin Park ^a  

^a Hannam University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

Author keywords

AMPK; COX 2; In vivo system; Mammalian cancer cells; Nitric oxide; SNP; Soy isoflavones (genistein)

Indexed keywords

ADENYLATE KINASE; CYCLOOXYGENASE 2; GENISTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOFLAVONE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PROSTAGLANDIN E2; ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; UPREGULATION; ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD; CHEMISTRY; DIET SUPPLEMENTATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; SOYBEAN; SPONTANEOUSLY HYPERTENSIVE RAT; SPRAGUE DAWLEY RAT; TUMOR CELL LINE;

MAMMALIA;

ANIMALS; CELL LINE, TUMOR; CYCLOOXYGENASE 2; DIETARY SUPPLEMENTS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; ISOFLAVONES; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, INBRED SHR; RATS, SPRAGUE-DAWLEY; SOYBEANS; UP-REGULATION;

EID: 34247868830     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1397.061     Document Type: Conference Paper

References (22)

1. MAYER, B. & B. HEMMENS. 1997. Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem. Sci. 22: 477-481.
2. MACMICKING, J., Q.-W. XIE & C. NATHAN. 1997. Nitric oxide and macrophage function. Ann. Rev. Immunol. 15: 323-350.
3. OHSHIMA, H. & H. BARTSCH. 1994. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat. Res. 305: 253-264.
4. YUN, H.Y., V.L. DAWSON & T.M. DAWSON. 1996. Neurobiology of nitric oxide. Crit. Rev. Neurobiol. 10: 291-316.
5. RICCIARDOLO, F.L., P.J. STERK, B. GASTON & G. FOLKERTS. 2004. Nitric oxide in health and disease of the respiratory system. Physiol. Rev. 84: 731-765.
6. BELTON, O.A., A. DUFFY, S. TOOMEY & D.J. FITZGERALD. 2003. Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis. Circulation 108: 3017-3023.
7. GHANAM, K., C. LAVAGNA, J.-L. BURGAUD, et al. 2000. Involvement of cyclooxygenase 2 in the protective effect of 17 β-estradiol on hypercholesterolemic rabbit aorta. Biochem. Biophys. Res. Commun. 275: 696-703.
8. MUSCARA, M.N. et al. 2000. Selective cyclo-oxygenase-2 inhibition with celecoxib elevates blood pressure and promotes leukocyte adherence. Br. J. Pharmacol. 129: 1423-1430.
9. MUTOH, M., M. TAKAHASHI, K. FUKUDA, et al. 2000. Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure. Carcinogenesis 21: 959-963.
10. BAKER, C.S., R.J. HALL, T.J. EVANS, et al. 1999. Cyclooxygenase-2 widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages. Arterioscler. Thromb. Vasc. Biol. 19: 646-655.
11. LIANG, Y.C., Y. HUANG, S. TSAI, et al. 1999. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis 20: 1945-1952.
12. HERMENEGILDO, C., P.J. OVIEDO, M.A. GARCIA-PEREZ, et al. 2005. Effects of phytoestrogens genistein and daidzein on prostacyclin production by human endothelial cells. J. Pharmcol. Exp. Ther. 315: 722-728.
13. HYSLOP, S. & G. DE NUCCI. 1993. Prostaglandin biosynthesis in the microcirculation: regulation by endothelial and non-endothelial factors. Prostaglandins Leukotrienes Essent. Fatty Acids 49: 723-760.
14. AHMAD, N., L.C. CHEN, M.A. GORDON, et al. 2002. Regulation of cyclooxygenase-2 by nitric oxide in activated hepatic macrophages during acute endotoxemia. J. Leukoc. Biol. 71: 1005-1011.
15. RIMBACH, G. et al. 2004. Sulfation of genistein alters its antioxidant properties and its effect on platelet aggregation and monocyte and endothelial function. Biochem. Biophys. Acta 1670: 229-237.
16. THOM, D.M., C.D. GARDNER & W.L. HASKELL. 1998. Potential health benefits of dietary phytoestrogens: a reviewof the clinical, epidemiological, and mechanistic evidence. J. Clin. Endocrinol. Metab. 83: 2223-2235.
17. LIN, W.W. & B.C. CHEN. 1999. Induction of cyclo-oxygenase-2 expression by methyl arachidonyl fluorophosphonate in murine J774 macrophages: roles of protein kinase C, ERKs and p38 MAPK. Br. J. Pharmacol. 126: 1419-1425.
18. XIE, W. & H.R. HERSCHMAN. 1996. Transcriptional regulation of prostaglandin synthase 2 gene expression by platelet-derived growth factor and serum. J. Biol. Chem. 271: 31742-31728.
19. COBB, M.H. & E.J. GOLDSMITH. 1995. How MAP kinases are regulated. J. Biol. Chem. 270: 148423-148426.
20. KNIGHT, D.C. & J.A. EDEN. 1996. A review of the clinical effects of phytoestrogens. Obstet. Gynecol. 87: 897-904.
21. ADLERCREUTZ, H. & W. MAZUR. 1997. Phyto-estrogens and Western diseases. Ann. Med. 29: 95-120.
22. AHN, K.S., E.J. NOH, H.L. ZHAO, et al. 2005. Inhibition of inducible nitric oxide synthase and cyclooxygenase II by Platycodon grandiflorum saponins via suppression of nuclear factor-kappaB activation in RAW 264.7 cells. Life Sci. 76: 2315-2328.